A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers
NCT01860508 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94
Last updated 2013-07-08
Summary
PFS
Conditions
Interventions
- DRUG
-
pemetrexed /carboplatin
Sponsors & Collaborators
-
Fudan University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-02-28
Countries
- China
Study Locations
More Related Trials
-
Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients
NCT01192243 ·Status: UNKNOWN ·Phase: PHASE2
-
Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer
NCT01481259 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.
NCT04453423 ·Status: UNKNOWN ·Phase: PHASE2
-
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer
NCT01194453 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study
NCT04716933 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients
NCT03489616 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
NCT04137588 ·Status: UNKNOWN
-
Study of KN046 With Chemotherapy in First Line Advanced NSCLC
NCT04054531 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer
NCT06109402 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
NCT07171606 ·Status: RECRUITING ·Phase: PHASE2
-
Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
NCT04956146 ·Status: UNKNOWN ·Phase: PHASE2
-
Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
NCT06132698 ·Status: RECRUITING ·Phase: PHASE2
-
Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
NCT03432598 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
NCT02944708 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
NCT00886678 ·Status: UNKNOWN ·Phase: PHASE2
-
Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
NCT04530227 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
NCT06440954 ·Status: RECRUITING ·Phase: PHASE2
-
High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
NCT02284490 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of PM1022 in Patients With Advanced Tumors
NCT05867771 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
NCT01333696 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
NCT04982549 ·Status: UNKNOWN ·Phase: PHASE2
-
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer
NCT02407366 ·Status: UNKNOWN ·Phase: PHASE2
-
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06208033 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
NCT02195453 ·Status: UNKNOWN ·Phase: PHASE4
-
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
NCT05520814 ·Status: UNKNOWN ·Phase: PHASE2